Medical Articles 5/29

Posted by rob on May 30, 2007 under Uncategorized | Be the First to Comment

Long-Term
Outcome of Unrelated Donor Transplantation for AML Using Myeloablative
Conditioning Incorporating Pretransplant Alemtuzumab.

Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.

Memorial Day

Posted by rob on May 28, 2007 under Uncategorized | Be the First to Comment

From  tinymercury

 

Medical Articles 5/26

Posted by rob on May 27, 2007 under Uncategorized | Be the First to Comment

STAT3 and PKC Differentially Regulate Telomerase Activity During Megakaryocytic Differentiation of K562 Cells.

Composite Nanoparticles Based on Hyaluronic Acid Chemically Cross-Linked with alpha,beta-Polyaspartylhydrazide.

Old Lighthouse, Isle Of Wright

Posted by rob on May 26, 2007 under Uncategorized | Be the First to Comment


From s0ulsurfing

Medical Articles 5/25

Posted by rob on May 25, 2007 under Uncategorized | Be the First to Comment

Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia.

c-Abl Tyrosine Kinase and Inhibition by the Cancer Drug Imatinib (Gleevec/STI-571).

Medical Articles 5/20

Posted by rob on May 21, 2007 under Uncategorized | Be the First to Comment

Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore.

Chronic myelogenous leukemia.

Medical Articles 5/18

Posted by rob on May 18, 2007 under Uncategorized | Be the First to Comment

Normal
hematopoietic function and multiple bone marrow clonal abnormalities in
a patient with acute myeloid leukemia after two mismatched stem-cell
transplants with graft failure and autologous reconstitution.

Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers.

Medical Articles 5/16

Posted by rob on May 16, 2007 under Uncategorized | Be the First to Comment

[The standard treatments for patients with hematological malignancies in Japan.]

Modulating Autophagy for Therapeutic Benefit.

Digoxin-Like Immunoreactive Factors Induce Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia.

Medical Articles 5/12

Posted by rob on May 12, 2007 under Uncategorized | Be the First to Comment

[Clinical Study on Prognosis of Acute Leukemia Subtypes Ly + AML and My + ALL.]

Effects
of Various Methoxyflavones on Vincristine Uptake and Multidrug
Resistance to Vincristine in P-gp-Overexpressing K562/ADM Cells.

Cell Genesys Starts More Trials for Immunotherapy

Posted by rob on May 11, 2007 under Uncategorized | Be the First to Comment

Cell Genesys have started three new clinical
trials for GVAX immunotherapy for leukemia, following encouraging
results in a phase II study.

The trials are now under way in
collaboration with the Johns Hopkins Sidney Kimmel Cancer Center in
patients with chronic myelogenous leukemia (CML). The studies include a
new phase II trial, an extension of the original phase II trial, and a
new phase I trial.

Cell Genesys Starts More Trials for Immunotherapy

Medical Articles 5/11

Posted by rob on under Uncategorized | Be the First to Comment

Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.

[Relationship Between Thymus Output Function in CML Patients and Their bcr-abl mRNA Levels.]

Medical Articles 5/10

Posted by rob on May 10, 2007 under Uncategorized | Be the First to Comment

[Organoarsenicals
derived from 2-phenyl-[1,3,2]dithiarsolan-4-yl)-methanol (AsIII) with
antileukaemic properties: from trypanosomicides to anticancer drugs.]

Diffuse alveolar damage and hemorrhage in acute myelogenous leukemia treated with corticosteroids.

Medical Articles 5/9

Posted by rob on May 9, 2007 under Uncategorized | Be the First to Comment

Laparoscopic appendectomy in a patient with acute myelogenous leukemia with neutropenia.

Studies in target-based treatment.

The
Novel Triterpenoid C-28 Methyl Ester of 2-Cyano-3, 12-Dioxoolen-1,
9-Dien-28-Oic Acid Inhibits Metastatic Murine Breast Tumor Growth
through Inactivation of STAT3 Signaling.

Medical Articles 5/4

Posted by rob on May 4, 2007 under Uncategorized | Be the First to Comment

High
levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP
E2-dependent suppression of C/EBP{alpha}-driven Myeloid Differentiation.

[New horizon of chronic myelogenous leukemia]

[New horizon of chronic myelogenous leukemia]

Medical Articles 5/2

Posted by rob on May 3, 2007 under Uncategorized | Be the First to Comment

Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Fludarabine
and busulfan as a myeloablative conditioning regimen for allogeneic
stem cell transplantation in high- and standard-risk leukemic patients.